일회용 어셈블리 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the single-use assemblies market size in 2026 is estimated at USD 2.41 billion, growing from 2025 value of USD 1.82 billion with 2031 projections showing USD 9.78 billion, growing at 32.34% CAGR over 2026-2031.

This report is Segmented by Product (Bag Assemblies, Filtration Assemblies, and More), Application (Filtration, Storage & Transport, Cell Culture/Harvest, and More), Solution (Standard Solutions, Customized Solutions), End User (Biopharmaceutical & Pharmaceutical Companies, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Single-Use Assemblies Market Trends and Insights

mRNA-Vaccine Platform Scale-Up Boosts Demand for Modular Fluid-Path Kits

The surge in mRNA vaccine output is driving demand for pre-validated, factory-repeatable single-use assemblies that can be replicated across multiple fill-finish suites without lengthy re-qualification. Thermo Fisher's USD 2 billion U.S. expansion earmarked for lipid-nanoparticle formulation exemplifies this shift. The FDA's Advanced Manufacturing Technologies program incentivizes firms to standardize on these modular kits, enabling validation cycles to drop from months to weeks. Manufacturers gain throughput advantages because single-use pathways remove the clean-in-place downtime found in stainless steel, aligning with national pandemic-preparedness policies that require rapid scale-up capacity.

Cell & Gene-Therapy Facilities Adopting Closed Single-Use Paths

Autologous therapies rely on highly segregated processing environments, making closed-loop single-use tubing and connector assemblies essential for sterility and cell viability. FDA guidance issued in May 2024 emphasizes closed systems to mitigate adventitious agent risk in CGT workflows. High-density microfluidic bioreactors demonstrated superior CAR-T expansion compared with legacy systems, with single-use formats enabling the gentle shear profiles required for cell functionality. As batch sizes mirror single-patient demand, the economic benefit of eliminating stainless-steel cleaning protocols is amplified, reinforcing adoption across new CGT facilities.

Leachables & Extractables Compliance Hurdles

The impending USP E&L chapter update scheduled for December 2025 imposes deeper toxicological scrutiny on polymer-based processing components, extending analytical timelines and escalating validation costs. Complex biologics formulations can catalyze unexpected chemical interactions with flexible film additives, forcing manufacturers to iterate material choices. Smaller firms with limited in-house mass-spectrometry capacity must outsource studies, lengthening development cycles and potentially slowing single-use assemblies market adoption.

Other drivers and restraints analyzed in the detailed report include:

1. Biologics and Biosimilars Capacity Expansion Worldwide
2. Cost-Savings vs. Stainless Steel & Faster Batch Changeovers
3. Disposal & Sustainability Concerns Around Plastic Waste

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Filtration assemblies generated the largest revenue in 2025, accounting for 32.18% of single-use assemblies market share. Their dominance is rooted in multi-step sterile-filtration mandates that span bulk media preparation to final drug substance polish. The single-use assemblies market size for bag assemblies is forecast to expand at the highest 33.85% CAGR to 2031 as biomanufacturers adopt flexible storage and preparation envelopes that integrate seamlessly with continuous processing lines. Across the forecast, mixing assemblies benefit from intensified upstream titer strategies that demand homogeneous nutrient distribution, while bottle assemblies retain niche demand where rigid containers withstand pressurized fills.

Process innovation is amplifying product substitution rates. Disposable depth-filter capsules paired with pre-sterilized connectors are replacing change-part stainless housings, shaving hours off turnaround windows. Hybrid facilities retain stainless large-volume hold tanks but deploy single-use filters and tubing for high-risk transfer steps to mitigate extractables exposure. Component vendors are integrating RFID tags for batch genealogy, aligning with real-time release analytics under ICH Q13. These advances embed digital tracking at the component level, improving deviation investigations and further entrenching disposables.

The single-use assemblies market size for cell culture mixing and harvest applications is projected to grow at 34.10% CAGR, fueled by intensified perfusion and seed-train bypass strategies that reduce plant footprint. Disposable bioreactors equipped with high-accuracy impeller designs maintain low shear, enhancing productivity for fragile cell lines used in gene therapy viral vectors. Filtration remains the largest application, securing 25.12% of 2025 revenue as regulators continue to mandate redundant sterilizing filters immediately before filling operations. Storage and transport assemblies gain traction in cold-chain biologics, where double-shelled bags mitigate temperature excursions during -80 °C shipments.

Adoption of single-use fill-finish manifolds is accelerating because preassembled tubing sets remove operator hose-barb connections, reducing microbial ingress risk. In parallel, process analytical sensors embedded in tubing walls provide in-line dissolved oxygen and pH readings, enabling automated feed-back loops that support Pharma 4.0 roadmaps. Across each application, vendors differentiate via film formulations that balance gas permeability with extractables control.

Complete Report Scope:

• By Product
  • Bag Assemblies
  • Filtration Assemblies
  • Bottle Assemblies
  • Mixing Assemblies
  • Tubing & Connector Assemblies
  • Others
• By Application
  • Filtration
  • Storage & Transport
  • Cell Culture/Harvest
  • Mixing & Buffer Preparation
  • Fill-Finish
  • Others
• By Solution
  • Standard Solutions
  • Customized Solutions
• By End User
  • Biopharmaceutical & Pharmaceutical Companies
  • Contract Manufacturing & Research Organisations (CMOs/CROs)
  • Academic & Research Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America led the single-use assemblies market with 41.55% share in 2025, supported by entrenched biologics capacity, a favorable FDA pathway for innovative manufacturing, and a dense ecosystem of component suppliers. Recent U.S. onshoring grants incentivize domestic resin production, alleviating supply-risk concerns. Canada's expanding monoclonal antibody facilities and Mexico's burgeoning fill-finish clusters reinforce regional demand, with trade-agreement harmonization easing cross-border logistics.

Asia-Pacific is the fastest-growing territory, registering a projected 33.98% CAGR through 2031. China and India are commissioning greenfield biologics parks that deploy top-to-bottom single-use systems to sidestep capital-intensive utilities. South Korea and Japan contribute premium demand for high-specification film chemistries. Government subsidies that tie funding to advanced manufacturing adoption accelerate penetration of single-use assemblies, while local irradiation build-outs are addressing sterilization bottlenecks.

Europe holds steady growth momentum underpinned by the European Commission's strategy to streamline biotech regulation and finance. Germany and Ireland maintain high adoption due to export-oriented biologics plants, whereas the United Kingdom leverages post-Brexit flexibility to pilot continuous manufacturing backed by single-use lines. Southern European nations are scaling contract manufacturing hubs linked to vaccine diplomacy programs, increasing regional equipment pull.

Middle East, Africa, and South America are nascent yet promising; modular single-use packages appeal to resource-constrained settings where water and steam are costly.

1. Thermo Fisher Scientific
2. Sartorius
3. Danaher Corp. (Cytiva & Pall)
4. Merck KGaA (MilliporeSigma)
5. Avantor Inc.
6. Saint-Gobain
7. 3M
8. Parker Hannifin
9. Corning
10. Eppendorf
11. Repligen Corp.
12. Entegris Inc.
13. Single Use Support GmbH
14. AdvantaPure (NewAge Industries Inc.)
15. HP NE LLC
16. Meissner Filtration Products
17. FlexBiosys Inc.
18. Trelleborg AB
19. Masterflex (Avantor)
20. Cole-Parmer Instrument Company

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 mRNA-Vaccine Platform Scale-Up Boosts Demand for Modular Fluid-Path Kits
  • 4.2.2 Cell & Gene-Therapy Facilities Adopting Closed Single-Use Paths
  • 4.2.3 Biologics and Biosimilars Capacity Expansion Worldwide
  • 4.2.4 Cost-Savings vs. Stainless Steel & Faster Batch Changeovers
  • 4.2.5 Regionalized Supply Chains Mandated by Regulators
  • 4.2.6 CDMO Needs Multi-Product Flexibility
• 4.3 Market Restraints
  • 4.3.1 Leachables & Extractables Compliance Hurdles
  • 4.3.2 Disposal & Sustainability Concerns Around Plastic Waste
  • 4.3.3 Medical-Grade Polymer Price Volatility
  • 4.3.4 Global Gamma-Irradiation Capacity Bottlenecks
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product
  • 5.1.1 Bag Assemblies
  • 5.1.2 Filtration Assemblies
  • 5.1.3 Bottle Assemblies
  • 5.1.4 Mixing Assemblies
  • 5.1.5 Tubing & Connector Assemblies
  • 5.1.6 Others
• 5.2 By Application
  • 5.2.1 Filtration
  • 5.2.2 Storage & Transport
  • 5.2.3 Cell Culture/Harvest
  • 5.2.4 Mixing & Buffer Preparation
  • 5.2.5 Fill-Finish
  • 5.2.6 Others
• 5.3 By Solution
  • 5.3.1 Standard Solutions
  • 5.3.2 Customized Solutions
• 5.4 By End User
  • 5.4.1 Biopharmaceutical & Pharmaceutical Companies
  • 5.4.2 Contract Manufacturing & Research Organisations (CMOs/CROs)
  • 5.4.3 Academic & Research Institutes
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 GCC
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Thermo Fisher Scientific Inc.
  • 6.3.2 Sartorius Stedim Biotech S.A.
  • 6.3.3 Danaher Corp. (Cytiva & Pall)
  • 6.3.4 Merck KGaA (MilliporeSigma)
  • 6.3.5 Avantor Inc.
  • 6.3.6 Saint-Gobain S.A.
  • 6.3.7 3M Company
  • 6.3.8 Parker Hannifin Corp.
  • 6.3.9 Corning Inc.
  • 6.3.10 Eppendorf SE
  • 6.3.11 Repligen Corp.
  • 6.3.12 Entegris Inc.
  • 6.3.13 Single Use Support GmbH
  • 6.3.14 AdvantaPure (NewAge Industries Inc.)
  • 6.3.15 HP NE LLC
  • 6.3.16 Meissner Filtration Products Inc.
  • 6.3.17 FlexBiosys Inc.
  • 6.3.18 Trelleborg AB
  • 6.3.19 Masterflex (Avantor)
  • 6.3.20 Cole-Parmer Instrument Company

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment